𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer

✍ Scribed by Nozomu Yanaihara; Michiho Nishioka; Takashi Kohno; Ayaka Otsuka; Aikou Okamoto; Kazunori Ochiai; Tadao Tanaka; Jun Yokota

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
399 KB
Volume
112
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Allelic imbalance on chromosome arm 22q has been detected in 50–70% of ovarian cancers, suggesting the presence of a tumor‐suppressor gene on this chromosome arm that is involved in ovarian carcinogenesis. Recently, we isolated a candidate tumor‐suppressor gene, MYO18B, at 22q12.1, which is deleted, mutated and hypermethylated in approximately 50% of lung cancers. In our study, we analyzed genetic and epigenetic alterations of the MYO18B gene in ovarian cancers. Missense MYO18B mutations were detected in 1 of 4 (25%) ovarian cancer cell lines and in 1 of 17 (5.9%) primary ovarian cancers. MYO18B expression was reduced in all 4 ovarian cancer cell lines and in 12 of 17 (71%) of primary ovarian cancers. MYO18B expression was restored by treatment with 5‐aza‐2′‐deoxycytidine and/or trichostatin A in 3 of 4 cell lines with reduced MYO18B expression, and hypermethylation of the promoter CpG island for MYO18B was observed in 2 of these 3 cell lines. Its hypermethylation was also observed in 2 of 15 (13%) primary ovarian cancers. Thus, it was indicated that MYO18B expression is reduced in a considerable fraction of ovarian cancers by several mechanisms, including hypermethylation, while the MYO18B gene is mutated in a small subset of ovarian cancers. The present results suggest that MYO18B alterations, including both epigenetic and genetic alterations, play an important role in ovarian carcinogenesis. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Genetic and epigenetic alterations of th
Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer
✍ Tetsuhiro Nakano; Masachika Tani; Michiho Nishioka; Takashi Kohno; Ayaka Otsuka; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

## Abstract Allelic imbalance (AI) on chromosome arm 22q has been detected in 20%–40% of colorectal cancers, suggesting that this chromosome arm has a tumor‐suppressor gene involved in colorectal carcinogenesis. Recently, we isolated a candidate tumor‐suppressor gene, __MYO18B__, at 22q12.1, that i

Refinement of an ovarian cancer tumour s
Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA
✍ Emma J. Bryan; Nicola A. Thomas; Karan Palmer; Elisabeth Dawson; Patricia Englef 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 2 views

Loss of heterozygosity on chromosome 22q was detected in 53% of 123 ovarian carcinomas, suggesting the presence of at least one tumour suppressor gene. We have refined the location of one possible tumour suppressor gene to the region between the microsatellite markers D22S299 and CYP2D. Located with

Mapping of a candidate colorectal cancer
Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8
✍ James M. Flanagan; Sue Healey; Joanne Young; Vicki Whitehall; Deborah A. Trott; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

## Abstract Loss of heterozygosity (LOH) on 8p occurs at high frequencies in many tumor types, including colorectal carcinoma (CRC). We previously used microcell‐mediated chromosome transfer (MMCT) into the CRC cell line SW620 to map a ∼7.7‐Mb colorectal cancer–suppressor region (CRCSR) at 8p22–23.

Analysis of the transcription regulator,
Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer
✍ James Flanagan; Sue Healey; Joanne Young; Vicki Whitehall; Georgia Chenevix-Tren 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB 👁 1 views

## Abstract Loss of heterozygosity (LOH) on the short arm of chromosome 8 occurs at high frequencies in many tumor types, including colorectal carcinoma. We have previously used microcell‐mediated chromosome transfer (MMCT) to map an approximately 7.7 Mb colorectal cancer suppressor region (CRCSR)

Expression of esophageal cancer related
Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo
✍ Lin-Wei Li; Xi-Ying Yu; Yang Yang; Chun-Peng Zhang; Li-Ping Guo; Shih-Hsin Lu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 384 KB 👁 1 views

## Abstract The ECRG4 gene was initially identified and cloned in our laboratory from human normal esophageal epithelium (GenBank accession no. AF325503). We revealed the expression of ECRG4 protein was downregulated in 68.5% (89/130) ESCC samples using tissue microarray. The low ECRG4 protein expr